Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of [11C]Cimbi-36 as an Agonist PET Radioligand for Imaging of 5-HT2A Receptors

NCT01778686 is registered in ClinicalTrials.gov with Gitte Moos Knudsen as lead sponsor.

NCT NCT01778686
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01778686 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of [11C]Cimbi-36 as an Agonist PET Radioligand for Imaging of 5-HT2A Receptors
Lead sponsor
Gitte Moos Knudsen
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2013
Completion date
November 30, 2013
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy